A US district court has invalidated two patents owned by American pharmaceutical firm Hospira, in a victory for German healthcare company Fresenius Kabi.
Pharmaceutical companies GSK and Pfizer yesterday announced that they will combine their consumer health businesses into a new joint venture with sales of approximately £9.8 billion ($12.7 billion).
The Federal Trade Commission (FTC) has approved an application by pharmaceutical company Teva to re-open and modify its decision and order regarding the 2012 merger of Actavis and Watson Pharmaceuticals.
The US Food and Drug Administration has announced a new programme to boost the innovation of safer medical devices and breakthrough technologies.
John Zurawski has joined Ballard Spahr as a partner in Philadelphia, after spending more than two years at McCarter & English.
The University of Wisconsin’s licensing arm, the Wisconsin Alumni Research Foundation, “improperly favoured” its own interests in breach of a contract related to patent licensing, according to Senior District Judge Joseph Bataillon.
Medical supplies company Wright Medical has lost its appeal for attorneys’ fees despite winning a patent dispute against medical technology provider Spineology.
Pfizer and Seattle-based biotech company Kineta Immuno-Oncology have signed a research and licensing agreement worth a potential $520 million.
The English High Court has ruled in favour of GSK in its patent dispute with Vectura, a UK-based pharmaceutical company which specialises in inhalable medicaments.
A Florida-based photo agency has accused San Francisco Plastic Surgery & Laser Center of using a copyright-protected image without authorisation on a web page about breast implants.